This inventor holds 1 USPTO granted patent. Top assignee: Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Filip Delaei: Innovator in Hepatitis Protection
Introduction
Filip Delaei is a notable inventor based in Reet, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of liver protection against viral hepatitis and alcoholic liver disease. His innovative work focuses on the use of specific inhibitors to combat the toxic effects of these diseases.
Latest Patents
Delaei holds a patent for his invention titled "Abin-mediated hepatitis protection." This patent relates to the use of the A20-binding inhibitor of NF-κB activation (ABIN), or a functional fragment or variant thereof, to protect against TNF-induced liver failure. The invention aims to prevent the toxic effects of viral hepatitis and alcoholic liver disease by overexpressing ABIN, thereby reducing lethality associated with these conditions. He has 1 patent to his name.
Career Highlights
Filip Delaei is affiliated with the Vlaams Interuniversitair Instituut Voor Biotechnologie, a prominent research institution in Belgium. His work at this institute has allowed him to explore innovative solutions to pressing health issues, particularly those affecting liver function.
Collaborations
Delaei has collaborated with esteemed colleagues such as Rudi Beyaert and Ben Wielockx. These partnerships have enhanced his research and contributed to the advancement of biotechnology in the context of liver disease.
Conclusion
Filip Delaei's contributions to hepatitis protection through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in the field of biotechnology.